Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBVD in Elderly and/or Cardiopathic Hodgkin's Lymphoma
NCT01523847Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Nov 2010
- Primary completion
- Oct 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in Hodgkin lymphoma (HL), sponsored by Fondazione Italiana Linfomi. Started Nov 2010; status: completed.
02
Drugs
doxorubicin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01523847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523847.